Home/Filings/4/0001213900-21-028172
4//SEC Filing

Nusbickel Thomas 4

Accession 0001213900-21-028172

CIK 0001410098other

Filed

May 19, 8:00 PM ET

Accepted

May 20, 4:18 PM ET

Size

7.7 KB

Accession

0001213900-21-028172

Insider Transaction Report

Form 4
Period: 2021-05-13
Nusbickel Thomas
EVP, Chief Commercial Officer
Transactions
  • Award

    Stock Option (Right to Buy Common Stock)

    2021-05-13+7,5007,500 total
    Exercise: $7.56Exp: 2031-05-13Common Stock (7,500 underlying)
  • Award

    Stock Option (Right to Buy Common Stock)

    2021-05-13+260,000260,000 total
    Exercise: $7.56Exp: 2031-05-13Common Stock (260,000 underlying)
Footnotes (2)
  • [F1]The options vest as follows: 160,000 will vest over four years in four (4) equal installments on the first four anniversaries of May 13, 2021. The remaining 100,000 options vest on the achievement of certain milestones, subject to continued employment.
  • [F2]These options were granted on May 13, 2021. These options shall vest in full on the first anniversary of the grant date, subject to continued employment.

Documents

1 file

Issuer

CorMedix Inc.

CIK 0001410098

Entity typeother

Related Parties

1
  • filerCIK 0001863281

Filing Metadata

Form type
4
Filed
May 19, 8:00 PM ET
Accepted
May 20, 4:18 PM ET
Size
7.7 KB